LMBR1 domain-containing protein 2 (LMBRD2)

LMBR1 domain-containing protein 2 (LMBRD2) is a highly conserved, membrane-bound protein implicated in the regulation of G protein-coupled receptor signaling, particularly as a negative regulator of beta-2 adrenergic receptor (ADRB2) activation. It is widely expressed, notably in neural tissues, and variants in the gene are associated with a spectrum of early-onset developmental and neurological disorders. The protein, while poorly characterized structurally, contains alternating cytoplasmic, helical, and transmembrane domains. LMBRD2 may influence other GPCRs, such as the angiotensin II receptor, and is thought to play a role in neurodevelopmental processes as evidenced by human genetic variants leading to intellectual disability, motor delays, seizures, and brain malformations. There are currently no drugs that specifically target LMBRD2, and it is not classified as a receptor or enzyme but rather as a regulator of receptor signaling, making it a candidate for future research into neurodevelopmental and signaling disorders[1][2][3][4].

Other names

G-protein coupled receptor-associated protein LMBRD2DENBADKFZp434H2226LMBD2LMBR1 domain-containing protein 2

Modulation of G protein-coupled receptor signaling pathways, predominantly by *negative regulation* of the beta-2 adrenergic receptor signaling[2][3][4] - Possible effects on other GPCR-related pathways (e.g., via angiotensin II receptor/AGTR1)[2][3]